Canadian evidence-based guideline for the first-line treatment of chronic lymphocytic leukemia

Chronic lymphocytic leukemia (cll) is the most common adult leukemia in North America. In Canada, no unified national guideline exists for the front-line treatment of cll; provincial guidelines vary and are largely based on funding. A group of clinical experts from across Canada developed a national...

Full description

Saved in:
Bibliographic Details
Published in:Current oncology (Toronto) 2018-10, Vol.25 (5), p.e461-474
Main Authors: Owen, C, Gerrie, A S, Banerji, V, Assouline, S, Chen, C, Robinson, K S, Lye, E, Fraser, G
Format: Article
Language:English
Subjects:
Canada
Evidence-Based Medicine
Humans
Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy
Practice Guideline
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Chronic lymphocytic leukemia (cll) is the most common adult leukemia in North America. In Canada, no unified national guideline exists for the front-line treatment of cll; provincial guidelines vary and are largely based on funding. A group of clinical experts from across Canada developed a national evidence-based treatment guideline to provide health care professionals with clear guidance on the first-line management of cll. Consensus recommendations based on available evidence are presented for the first-line treatment of cll.
ISSN:1718-7729
1198-0052
1718-7729
DOI:10.3747/co.25.4092